Introduction
NK cells are innate immune lymphocytes active in host defense against pathogens and tumors. They mediate these activities through direct killing of transformed or infected cells and production of cytokines such as IFN-, TNF-and GM-CSF 1 . NK cell functions are regulated by cytokine feedback loops, contact with dendritic cells, immune complexes and direct interactions with the infected or transformed cells which serve as targets for their cytotoxicity [2] [3] [4] . NK cell specificity for diseased cells is determined by a balance of signals generated by diverse stimulatory and inhibitory receptors 5 . Several inhibitory NK cell receptors have specificity for MHC class I allotypes. These receptors survey for MHC class I molecules on potential targets, the NK cells being inhibited by cells with normal expression but responding to cells with compromised levels of class I on their surface 6, 7 . In the context of allogeneic hematopoietic cell transplantation, the specificity of inhibitory NK cell receptors for class I can have significant impact on graft rejection, graft versus host disease (GVHD) and graft versus leukemia effects (GVL) [8] [9] [10] .
A key feature of NK cell class I receptor families is their extensive diversity, which plays out within individuals and across populations of individuals and species [11] [12] [13] . The distribution of multiple receptor families and multiple receptors within a family on NK cell subsets accounts for the diversity within an individual's NK cell receptor repertoire [13] [14] [15] . In humans, families of lectin-like and Ig-like membrane glycoproteins share the responsibility of detecting host cell class I expression, thereby maintaining NK cell tolerance 13 . The inhibitory receptors include the lectin-like receptor CD94:NKG2A that recognizes the non-classical HLA-E class I molecule and is encoded in the NK Complex
For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From . By contrast, individual KIR family members exhibit finer specificity for HLA class I allotypes and can distinguish between groups of HLA-A, -B and -C allotypes 13, [23] [24] [25] [26] [27] [28] [29] . The more focused specificity of inhibitory KIR governs human NK cell alloreactions and likely renders NK cells responsive to selective alterations to class I expression on virally-infected and/or transformed cells 30 .
Stimulatory members of the lectin-like (CD94:NKG2C/D) and Ig-like (KIR2/3DS) receptors have also been described, some of which have overlapping class I specificity and antibody epitopes with their inhibitory counterparts 14 . The exact role of these stimulatory receptors remains a subject for debate, however, their capacity to activate NK cells is usually dominated by the negative signals generated through inhibitory KIR and/or CD94:NKG2A class I recognition 13 . Demonstration that NKG2D recognizes MICA/B and Rae1, and that a stimulatory class I receptor of mice recognizes an MCMV For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From class I-like decoy protein suggests that the stimulatory class I receptors may have evolved to detect class I-like structures encoded by genes located within and away from the MHC [31] [32] [33] [34] .
The specificities of both the inhibitory and stimulatory members of KIR, ILT-2 and CD94:NKG2 receptor families have mainly been assessed with assays of NK cell function, although direct binding studies have also been used [35] [36] [37] [38] [39] . The functional determination of receptor specificity has usually employed cytolytic assays with NK cell lines or clones as effectors and class I-deficient cells transfected with individual class I alleles as targets. This approach has allowed the identification of the several KIR, LILR and CD94:NKG2 specificities for HLA class I. Limiting the approach is its need for activated NK cell clones and lines derived from long-term culture in high doses of IL-2 13, [24] [25] [26] [27] [28] [29] . Given that a defining aspect of NK cell biology is the ability to work early in the immune response, we have investigated the HLA class I specificity of inhibitory NK cell receptors in short-term (12-24 h) cytokine-cultured NK cells purified from the peripheral blood of human donors. By adapting the ELISpot technique for IFN-and granzyme B secretion and intracellular cytokine staining (ICS) for IFN-we studied the response of NK cells to class I deficient cells and their inhibition by HLA class I allotypes, under conditions more like those of an early stage immune response.
Material and methods
Cells, and cytokines. EBV-transformed B cell lines, MHC class I-deficient 721.221, and 221-B*5801, -Cw*0304, -Cw*0401, -Cw*0702 class I transfectants were cultured in were purified from buffy coats derived from the blood of healthy donors and obtained from Stanford Blood Center (Stanford, CA) by separation on a Ficoll-Hypaque gradient.
Genomic DNA was prepared from PBMC using a QIAamp Blood kit (Qiagen, Valencia, CA). KIR typing of genomic DNA was performed as described previously 40, 41 . KIR3DL1 allele typing were performed as described previously 42 with the addition of one primer pair (forward:5'-CCATCGGTCCCATGATGCT-3',reverse: 5'-ACGTTCATGGGCTCCCCG-3') which amplifies 3DL1*002.
NK cell purification. Purified, resting NK cells were obtained from frozen PBMC by magnetic depletion of T and B lymphocytes and monocytes using a cocktail of biotinconjugated monoclonal antibodies against CD3, CD4, CD14, CD15, CD19, CD36, CD123, anti-biotin microbeads, LS separation columns and midiMACS magnet (Miltenyi Biotec, Auburn, CA). After depletion, NK cell preparations (CD56+/CD3-) were from 85 to 95 % pure and contamination with CD14+, CD19+, CD3+ cells was <1% and 5-15% for lineage negative cells. . Both LILRB1 (previously called LIR-1 or ILT2) and CD94:NKG2A recognize a broad range of HLA-C allotypes, the latter through HLA-C leader peptides bound to HLA-E. 17, 20, 21, 44 . Because of the prevalence of HLA-C mediated inhibition it was first examined using the ELISpot system. 
Results

An ELISpot technique for the study of class I-mediated regulation of NK cells
Correlations between class I receptor expression and functional inhibition of resting and short-term activated NK cells.
To assess the contribution of different receptors to HLA-C mediated inhibition of NK cell function, we sought donors with KIR genotyes that lack the stimulatory KIR (KIR2DS1, 2DS2 and 2DS3). These stimulatory KIR could have complicated the analysis in two ways: first by interacting with HLA-C to activate NK cells, second by crossreacting with the monoclonal antibodies used to detect inhibitory HLA-C specific KIR 45 . NK cells from the selected donors (Table I) In continuing to study this difference, we further simplified the experimental system so that the action of a single inhibitory receptor could be studied. This was achieved by using HLA-Cw*0702 as the inhibitory ligand; it interacts with inhibitory KIR, but does not furnish an HLA-E binding peptide to make a CD94:NKG2A ligand 17, 13 . In addition, LILRB1 does not interact with HLA-Cw*0702 44 . When 221 transfectants expressing HLA-Cw*0702 is a ligand for KIR2DL2 and 2DL3 13, 25, 46 . Donor 17 lacked genes for KIR2DL2 and the stimulatory receptors, KIR2DS2/2DS3, so the GL-183 monoclonal antibody could be used to enumerate NK cells expressing KIR2DL3. An experiment analogous to that shown in Figure 3 Figure 5A upper panels) showed the effect, but the frequency of cells responding with IL-2 was higher, as expected from previous ELISpot analysis (Figures 1,3,4 
Functional inhibition of NK cells expressing KIR3DL1 allotypes with high and low levels of KIR3DL1.
A feature of the polymorphism of KIR3DL1 is that some allotypes are distinguished by different levels of cell-surface expression 47, 48 . Flow cytometric analysis of IFNproduction by NK cells provided a method for direct comparison of the functional potential of allotypes expressed at different level. The analysis of two donors, both of whom are KIR3DL1 heterozygotes, is shown in Figure 6 . 
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Previous reports have shown that IL-12, IL-15, and TGF-V induce the expression of CD94/NKG2A on activated human T lymphocytes [52] [53] [54] . Analogous to this, we observed that culture with IL-12 increased the frequency of NK cells expressing the CD94:NKG2A receptor, while IL-2 had minimal effect on receptor expression. Although not definitive, our results point to this increase being due to induction of CD94:NKG2A expression rather than selective expansion of cells expressing this receptor. In contrast, no change in either KIR or LILRB expression was detected, as previously reported 55 . Both IL-2 and IL-12 activate NK cell functions in similar ways, however, IL-12 acts early on NK cell functions in vivo, whereas, IL-2, a product of antigen-specific T h cells, acts later 3, 56 . IL-12 is produced by diverse populations of antigen presenting cells, being secreted rapidly and in large quantities by dendritic cell (DC) subsets [57] [58] [59] . By increasing the abundance of Inhibitory KIR genes (2DL1-5 and 3DL1,2) encode for class I receptors with long cytoplasmic tails containing inhibitory ITIM motifs 16 . Despite possessing a long cytoplasmic tail with ITIM motifs, KIR2DL4 has both inhibitory and stimulatory function [64] [65] [66] [67] . 4 Stimulatory KIR genes (2DS1-5 and 3DS1) encode receptors with short cytoplasmic tails that lack ITIM motifs. Table 1 ) by HLA-Cw*0401; two independent experiments gave similar results. Table 1 ). Flow cytometric analysis with the GL-183 antibody (anti-KIR2DL2/3, 2DS2) was used to determine the frequency (10%) of Table 1 ). 
